Marcio H Malogolowkin Selected Research

Marcio H Malogolowkin Research Topics

14	Hepatoblastoma 01/2022 - 06/2006
12	Neoplasms (Cancer) 10/2022 - 06/2002
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2019 - 10/2013
2	Wilms Tumor (Wilm's Tumor) 04/2014 - 12/2009
2	Margins of Excision 09/2012 - 12/2007
2	Hepatocellular Carcinoma (Hepatoma) 04/2003 - 06/2002
1	Hypokalemia 01/2022
1	Febrile Neutropenia 01/2022
1	Mucositis 01/2022
1	Infections 01/2022
1	Hemorrhage 04/2020
1	Sepsis (Septicemia) 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Gonadoblastoma 01/2018
1	Dysgerminoma 01/2018
1	Spontaneous Rupture 01/2017
1	Hyperglycemia 10/2013
1	Osteosarcoma (Osteogenic Sarcoma) 09/2012
1	Ewing Sarcoma (Sarcoma, Ewing) 09/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2012
1	Necrosis 09/2012
1	Cardiotoxicity 05/2008
1	Neoplasm Metastasis (Metastasis) 12/2007
1	Choriocarcinoma 07/2007
1	Critical Illness (Critically Ill) 07/2007

8	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 06/2002
7	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 06/2002
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 06/2002
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2022 - 12/2007
4	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 06/2002
3	Fetal Proteins (Fetoprotein)IBA 01/2019 - 01/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 06/2017 - 08/2012
2	Tumor Biomarkers (Tumor Markers)IBA 10/2019 - 07/2007
2	Bleomycin (Blenoxane)FDA LinkGeneric 04/2017 - 10/2013
2	Etoposide (VP 16)FDA LinkGeneric 04/2017 - 10/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 04/2014
1	Bevacizumab (Avastin)FDA Link 04/2014
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	ORALIT (ORS)IBA 10/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2013
1	Insulin-Like PeptidesIBA 08/2012
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2012
1	TOR Serine-Threonine KinasesIBA 08/2012
1	PlatinumIBA 06/2006